Last reviewed · How we verify
generic single tablet TAF/FTC/DTG — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
generic single tablet TAF/FTC/DTG (generic single tablet TAF/FTC/DTG) — The HIV Netherlands Australia Thailand Research Collaboration.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| generic single tablet TAF/FTC/DTG TARGET | generic single tablet TAF/FTC/DTG | The HIV Netherlands Australia Thailand Research Collaboration | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- generic single tablet TAF/FTC/DTG CI watch — RSS
- generic single tablet TAF/FTC/DTG CI watch — Atom
- generic single tablet TAF/FTC/DTG CI watch — JSON
- generic single tablet TAF/FTC/DTG alone — RSS
Cite this brief
Drug Landscape (2026). generic single tablet TAF/FTC/DTG — Competitive Intelligence Brief. https://druglandscape.com/ci/generic-single-tablet-taf-ftc-dtg. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing